GAAP to Non-GAAP GUIDANCE (Dollars in millions, except per share data) Annual FY'27 Adjusted for FY'27 Comparison Reported Change (Acquisition) Low High FY26 FY26 FY26 GAAP REVENUE $ 2,684 $ 2,709 $ 2,544 $ 2,544 $ — Growth 5.5 % 6.5 % Deconversions* 23 23 43 43 — Acquisition 2 2 — 5 (5) NON-GAAP ADJUSTED REVENUE** $ 2,659 $ 2,684 $ 2,502 $ 2,496 $ 5 Non-GAAP Adjusted Growth 6.3 % 7.3 % GAAP OPERATING EXPENSES $ 2,025 $ 2,039 $ 1,909 $ 1,909 $ — Growth 6.1 % 6.8 % Deconversion costs* 5 5 13 13 — Acquisition costs 3 3 — 8 (8) Gain on assets, net — — (7) (7) — NON-GAAP ADJUSTED OPERATING EXPENSES** $ 2,018 $ 2,031 $ 1,903 $ 1,895 $ 8 Non-GAAP Adjusted Growth 6.0 % 6.7 % GAAP OPERATING INCOME $ 658 $ 670 $ 635 $ 635 $ — Growth 3.7 % 5.5 % GAAP OPERATING MARGIN 24.5 % 24.7 % 25.0 % 25.0 % NON-GAAP ADJUSTED OPERATING INCOME** $ 641 $ 653 $ 598 $ 601 $ (3) Non-GAAP Adjusted Growth 7.2 % 9.1 % NON-GAAP ADJUSTED OPERATING MARGIN 24.1 % 24.3 % 23.9 % 24.1 % GAAP EPS $ 7.33 $ 7.38 $ 6.98 $ 6.98 $ — Growth 5.0 % 5.7 % *Deconversion revenue and related operating expenses for fiscal year 2027 are based on the lowest actual recent historical results. See the Company’s Form 8-K filed with the Securities and Exchange Commission on August 3, 2023. **GAAP to Non-GAAP revenue, operating expenses, and operating income may not foot due to rounding. 10 Balance Sheet and Cash Flow Review • Cash and cash equivalents were $12 million at June 30, 2026, compared to $102 million at June 30, 2025. • Trade receivables were $349 million at June 30, 2026, and $318 million at June 30, 2025. • The Company had $40 million of borrowings at June 30, 2026, compared to $0 of borrowings at June 30, 2025. • Deferred revenue was $372 million at June 30, 2026, compared to $363 million at June 30, 2025. • Stockholders' equity dec

later in the release …

the item shown at left

other guidance in this release

Text is the filed exhibit, verbatim.